Tenet Healthcare director Stephen Rusckowski resigns from board

Tenet Healthcare Corporation reported that Stephen H. Rusckowski has resigned from its board of directors, effective immediately, as of November 21, 2025.

Rhea-AI Filing Summary

Tenet Healthcare Corporation reported that Stephen H. Rusckowski has resigned from its board of directors, effective immediately, as of November 21, 2025. Following his departure, the board reduced its size from thirteen to twelve directors. The filing does not describe any changes to management roles or the company’s strategic direction beyond this board adjustment.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Tenet Healthcare (THC) announce in this 8-K?

Tenet Healthcare announced that Stephen H. Rusckowski resigned from its board of directors, effective immediately on November 21, 2025, and the board size was reduced from thirteen to twelve members.

When did Stephen H. Rusckowski resign from Tenet Healthcare's board?

Stephen H. Rusckowski notified Tenet Healthcare of his decision to resign from the board on November 21, 2025, and the resignation was effective immediately on that date.

How did Tenet Healthcare's board size change after the resignation?

In connection with the resignation of Stephen H. Rusckowski, Tenet Healthcare's board of directors decreased in size from thirteen to twelve directors.

Does this 8-K report any changes to Tenet Healthcare's executive management?

The 8-K reports a change only in the board of directors. It does not state any changes to executive management roles or responsibilities.

Which securities of Tenet Healthcare are listed on the NYSE?

Tenet Healthcare lists its common stock under the symbol THC and its 6.875% Senior Notes due 2031 under the symbol THC31 on the NYSE.

Is Tenet Healthcare classified as an emerging growth company in this filing?

The filing includes the standard emerging growth company check box language, but it does not state that Tenet Healthcare is an emerging growth company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 04:05 PM EST Learn about SEC filing dates

0000070318false00000703182025-11-212025-11-210000070318us-gaap:CommonStockMemberexch:XNYS2025-11-212025-11-210000070318us-gaap:SeniorNotesMemberexch:XNYS2025-11-212025-11-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 _______________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 _______________

Date of Report: November 21, 2025

(Date of earliest event reported)

 _______________

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

Nevada

1-7293

95-2557091

(State of Incorporation)

(Commission File Number)

(IRS Employer Identification Number)

14201 Dallas Parkway

Dallas, TX 75254

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.05 par value

THC

NYSE

6.875% Senior Notes due 2031

THC31

NYSE

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 21, 2025, Stephen H. Rusckowski notified Tenet Healthcare Corporation (the “Company”) of his decision to resign from the Company’s board of directors (the “Board”), effective immediately. In connection with Mr. Rusckowski’s resignation, the Board decreased the size of the Board from thirteen to twelve directors.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						TENET HEALTHCARE CORPORATION
Date: November 24, 2025			By:			/s/ THOMAS ARNST
						Name:			Thomas Arnst
						Title:			Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary